Age-dependent effects in the transmission and control of COVID-19 epidemics
- PMID: 32546824
- DOI: 10.1038/s41591-020-0962-9
Age-dependent effects in the transmission and control of COVID-19 epidemics
Abstract
The COVID-19 pandemic has shown a markedly low proportion of cases among children1-4. Age disparities in observed cases could be explained by children having lower susceptibility to infection, lower propensity to show clinical symptoms or both. We evaluate these possibilities by fitting an age-structured mathematical model to epidemic data from China, Italy, Japan, Singapore, Canada and South Korea. We estimate that susceptibility to infection in individuals under 20 years of age is approximately half that of adults aged over 20 years, and that clinical symptoms manifest in 21% (95% credible interval: 12-31%) of infections in 10- to 19-year-olds, rising to 69% (57-82%) of infections in people aged over 70 years. Accordingly, we find that interventions aimed at children might have a relatively small impact on reducing SARS-CoV-2 transmission, particularly if the transmissibility of subclinical infections is low. Our age-specific clinical fraction and susceptibility estimates have implications for the expected global burden of COVID-19, as a result of demographic differences across settings. In countries with younger population structures-such as many low-income countries-the expected per capita incidence of clinical cases would be lower than in countries with older population structures, although it is likely that comorbidities in low-income countries will also influence disease severity. Without effective control measures, regions with relatively older populations could see disproportionally more cases of COVID-19, particularly in the later stages of an unmitigated epidemic.
Comment in
-
Which Pediatric Asymptomatic Patients Should Be Tested for COVID-19?Pediatr Ann. 2020 Aug 1;49(8):e328. doi: 10.3928/19382359-20200625-02. Pediatr Ann. 2020. PMID: 32785714 No abstract available.
-
What new COVID variants mean for schools is not yet clear.Nature. 2021 Jan;589(7843):503. doi: 10.1038/d41586-021-00139-3. Nature. 2021. PMID: 33479532 No abstract available.
Similar articles
-
Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide.PLoS One. 2020 Aug 20;15(8):e0237959. doi: 10.1371/journal.pone.0237959. eCollection 2020. PLoS One. 2020. PMID: 32817662 Free PMC article.
-
Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study.BMC Med. 2020 Oct 14;18(1):324. doi: 10.1186/s12916-020-01789-2. BMC Med. 2020. PMID: 33050951 Free PMC article.
-
The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age.Sci Rep. 2020 Oct 6;10(1):16642. doi: 10.1038/s41598-020-73777-8. Sci Rep. 2020. PMID: 33024235 Free PMC article.
-
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.Lancet Infect Dis. 2020 Sep;20(9):e238-e244. doi: 10.1016/S1473-3099(20)30484-9. Epub 2020 Jul 3. Lancet Infect Dis. 2020. PMID: 32628905 Free PMC article. Review.
-
Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?Biomolecules. 2020 Sep 11;10(9):1312. doi: 10.3390/biom10091312. Biomolecules. 2020. PMID: 32933047 Free PMC article. Review.
Cited by
-
Anatomy of digital contact tracing: Role of age, transmission setting, adoption, and case detection.Sci Adv. 2021 Apr 9;7(15):eabd8750. doi: 10.1126/sciadv.abd8750. Print 2021 Apr. Sci Adv. 2021. PMID: 33712416 Free PMC article.
-
Age cohorts stratified according to age-distributions of COVID-19 morbidity statistics identify uniquely age-dependent CD3+CD8+ T-cell lymphocytopenia in COVID-19 patients without comorbidities on admission.Aging (Albany NY). 2021 Mar 10;13(6):7713-7722. doi: 10.18632/aging.202691. Epub 2021 Mar 10. Aging (Albany NY). 2021. PMID: 33714947 Free PMC article.
-
Role of modelling in COVID-19 policy development.Paediatr Respir Rev. 2020 Sep;35:57-60. doi: 10.1016/j.prrv.2020.06.013. Epub 2020 Jun 18. Paediatr Respir Rev. 2020. PMID: 32690354 Free PMC article. Review.
-
The prevalence of antibodies to SARS-CoV-2 among blood donors in China.Nat Commun. 2021 Mar 2;12(1):1383. doi: 10.1038/s41467-021-21503-x. Nat Commun. 2021. PMID: 33654063 Free PMC article.
-
Therapeutic MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets.Res Sq [Preprint]. 2020 Oct 12:rs.3.rs-89433. doi: 10.21203/rs.3.rs-89433/v1. Res Sq. 2020. Update in: Nat Microbiol. 2021 Jan;6(1):11-18. doi: 10.1038/s41564-020-00835-2 PMID: 33052328 Free PMC article. Updated. Preprint.
References
-
- Liu, Z., Xing, B. & Xue Za, Z. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin. J. Epidemiol. 41, 145–151 (2020).
-
- Sun, K., Chen, J. & Viboud, C. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. Lancet Digit. Health 2, e201–e208 (2020). - DOI
-
- Cereda, D. et al. The early phase of the COVID-19 outbreak in Lombardy, Italy. Preprint at https://arxiv.org/pdf/2003.09320.pdf (2020).
-
- Shim, E., Tariq, A., Choi, W., Lee, Y. & Chowell, G. Transmission potential and severity of COVID-19 in South Korea. Int. J. Infect. Dis. 93, 339–344 (2020). - DOI
-
- Dong, Y. et al. Epidemiological characteristics of 2,143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 145, e20200702 (2020). - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous